Eupraxia Pharmaceuticals Statistics

Total Valuation

TSX:EPRX has a market cap or net worth of CAD 618.11 million. The enterprise value is 546.44 million.

Market Cap	618.11M
Enterprise Value	546.44M

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:EPRX has 61.50 million shares outstanding. The number of shares has increased by 17.76% in one year.

Current Share Class	61.50M
Shares Outstanding	61.50M
Shares Change (YoY)	+17.76%
Shares Change (QoQ)	+38.96%
Owned by Insiders (%)	18.07%
Owned by Institutions (%)	24.17%
Float	45.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.60
P/TBV Ratio	8.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.70
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.68

Financial Position

The company has a current ratio of 15.12, with a Debt / Equity ratio of 0.00.

Current Ratio	15.12
Quick Ratio	14.43
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.76% and return on invested capital (ROIC) is -42.70%.

Return on Equity (ROE)	-68.76%
Return on Assets (ROA)	-39.67%
Return on Invested Capital (ROIC)	-42.70%
Return on Capital Employed (ROCE)	-47.73%
Weighted Average Cost of Capital (WACC)	11.82%
Revenue Per Employee	n/a
Profits Per Employee	-1.15M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:EPRX has paid 26,176 in taxes.

Income Tax	26,176
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +91.81% in the last 52 weeks. The beta is 1.38, so TSX:EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.38
52-Week Price Change	+91.81%
50-Day Moving Average	11.27
200-Day Moving Average	8.77
Relative Strength Index (RSI)	40.73
Average Volume (20 Days)	97,769

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.70M
Pretax Income	-52.91M
Net Income	-56.36M
EBITDA	-52.47M
EBIT	-52.70M
Earnings Per Share (EPS)	-1.41

Full Income Statement

Balance Sheet

The company has 110.46 million in cash and 211,649 in debt, with a net cash position of 110.25 million or 1.79 per share.

Cash & Cash Equivalents	110.46M
Total Debt	211,649
Net Cash	110.25M
Net Cash Per Share	1.79
Equity (Book Value)	110.30M
Book Value Per Share	1.38
Working Capital	108.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -39.15 million and capital expenditures -807,517, giving a free cash flow of -39.96 million.

Operating Cash Flow	-39.15M
Capital Expenditures	-807,517
Depreciation & Amortization	225,944
Net Borrowing	n/a
Free Cash Flow	-39.96M
FCF Per Share	-0.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.76%
Shareholder Yield	-17.76%
Earnings Yield	-9.12%
FCF Yield	-6.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2